- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07849023
Application of Precision Partial Intersphincteric Resection (PPISR)
Application of Precision Partial Intersphincteric Resection (PPISR) in Patients With Ultra-low Rectal Cancer
The goal of this study is to establish a standardized operating procedure for Precision Partial Intersphincteric Resection (PPISR), and to evaluate its surgical safety, functional benefits, and oncological efficacy.
Studieoversikt
Status
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: shaotang li
- Telefonnummer: 86+18815039766
- E-post: lishaotang163@163.com
Studiesteder
-
-
Zhejiang
-
Wenzhou, Zhejiang, Kina, 325000
- Rekruttering
- First Affiliated Hospital of Wenzhou Medical University
-
Ta kontakt med:
- chunwu zhang
- Telefonnummer: 86+0577-55578055
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients aged 18-75 years old
- Pathology suggestive of moderately to highly differentiated rectal adenocarcinoma
- Tumor lower margin ≤ 5 cm from the anal verge
- Pre-operative tumor (T) staging of T1-T3 and T1-T2 below the level of the anal raphe muscle
- No distant metastasis such as lung, liver and other organs
Exclusion Criteria:
- Preoperative patients with severe underlying diseases (such as severe liver and kidney function, cardiopulmonary function, coagulation dysfunction, etc.)
- Patients with malignant tumors in other parts of the body
- Patients who underwent emergency surgery due to acute perforation, obstruction, etc.
- Patients with tumor infiltration of peripheral organs during the operation, which required combined resection or palliative resection
- Patients who had a mid-opening laparoscopic operation for various reasons -during the operation
- Patients with poor anal function before operation, which is not suitable for anus preservation surgery.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: PPISR
The experimental group underwent the PPISR procedure. |
The experimental group underwent the PPISR procedure. The surgical process was as follows:
|
|
Aktiv komparator: Traditional ISR
The control group underwent the traditional ISR procedure |
The control group underwent the traditional ISR procedure. The surgical process was as follows:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative anal function as assessed by Wexner Score
Tidsramme: At 3 and 6 months postoperatively
|
Scale Title: Wexner Fecal Incontinence Score. The minimum values:0. The maximum values:20. Higher scores mean a worse outcome. |
At 3 and 6 months postoperatively
|
|
Postoperative quality of life as assessed by EORTC QLQ-C30
Tidsramme: At 1 year postoperatively
|
Scale Title: European Organization for Research and Treatment of cancer Quality of Life Questionnaire. The minimum values:0. The maximum values:100. Higher scores mean a worse outcome. |
At 1 year postoperatively
|
|
3-year local recurrence rate as assessed by abdominal contrast-enhanced MRI
Tidsramme: 3 years postoperatively
|
Participants have an MRI every 3 months postoperatively |
3 years postoperatively
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Circumferential resection margin negative rate
Tidsramme: Immediately after the pathology results come out
|
Immediately after the pathology results come out
|
|
|
intraoperative blood loss
Tidsramme: Immediately after the surgery
|
Immediately after the surgery
|
|
|
Postoperative-related complication incidence
Tidsramme: From the end of surgery to 3 months postoperatively
|
Complications include postoperative bleeding, abdominal cavity infection, thoracic cavity infection, urinary tract infection, etc. |
From the end of surgery to 3 months postoperatively
|
|
Postoperative hospital stay duration
Tidsramme: From the end of surgery to discharge
|
From the end of surgery to discharge
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- KY2025-246
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .